Login / Signup

Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.

Veronica DusiFederica DagradiCarla SpazzoliniLia CrottiPaolo CereaFulvio L F GiovenzanaGiulia MusuMatteo PedrazziniMargherita TorchioPeter J Schwartz
Published in: European heart journal (2024)
Beta-blockers often shorten QTc, thus changing risk scores and ICD indications for primary prevention. Yearly risk reassessment with therapy optimization leads to fewer ICD implants (3%) without increasing life-threatening events.
Keyphrases
  • case report
  • mesenchymal stem cells
  • angiotensin converting enzyme
  • drug induced
  • angiotensin ii